This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Drug Delivery International Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Claire Helen Ordoyno: Innovator in Drug Delivery Systems
Introduction
Claire Helen Ordoyno is a notable inventor based in Strathclyde, GB. She has made significant contributions to the field of drug delivery systems, particularly through her innovative patent for a sustained release tablet. Her work focuses on improving the efficacy and delivery of therapeutic agents.
Latest Patents
Claire holds a patent for a method of forming an erodible sustained release tablet. The patent outlines a process that includes mixing one or more therapeutic agents, one or more disintegrants, and one or more molten waxes while retaining the wax in molten form. The method further involves solidifying and granulating the mixture, followed by forming a tablet through the compression of the granules. This invention is crucial for developing sustained release tablets that enhance patient compliance and therapeutic outcomes.
Career Highlights
Throughout her career, Claire has demonstrated a commitment to advancing pharmaceutical technologies. Her innovative approach to drug formulation has positioned her as a key figure in the industry. She is currently associated with Drug Delivery International Limited, where she continues to work on groundbreaking projects.
Collaborations
Claire has collaborated with esteemed colleagues, including Howard Norman Ernest Stevens and Alexander Balfour Mullen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Claire Helen Ordoyno's contributions to the field of drug delivery systems exemplify her dedication to improving healthcare through innovation. Her patent for a sustained release tablet is a testament to her expertise and commitment to advancing pharmaceutical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile